AUM$1.3M
Expense Ratio0.65%
NAV$17.26
Holdings31
InceptionNov 22, 2021
Price Chart
Key Statistics
Previous Close
N/ADay Range
N/A52-Week Range
N/AAvg Volume
N/ADividend Yield
N/AExpense Ratio
0.65%AUM
$1.3MShares Outstanding
N/ASector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 72.77% |
| Technology | 18.32% |
| Industrials | 6.13% |
| Basic Materials | 2.79% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 80.14% |
| Ireland | 6.16% |
| Israel | 4.65% |
| United Kingdom | 4.65% |
| Germany | 2.39% |
| Canada | 2.02% |
Fund Information
- Issuer
- Direxion
- Category
- Healthcare
- Types
- Technology
- Inception Date
- Nov 22, 2021
- Description
- The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index is provided by S&P Dow Jones Indices LLC (the “index provider”) and is designed to measure the performance of U.S.-listed securities, including depositary receipts, of companies involved in the nanotechnology industry. The fund is non-diversified.
Similar ETFs
The Direxion Nanotechnology ETF (TYNE) is an exchange-traded fund issued by Direxion that launched on Nov 22, 2021. It currently manages $1.3M in assets under management. The fund charges an expense ratio of 0.65%. The fund holds 31 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 60.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | BRKR | Bruker Biosciences Corp | 13.83% | 1,580 | $116K |
| 2 | BEAM | Beam Therapeutics Inc | 11.13% | 2,230 | $93K |
| 3 | LQDA | Liquidia Technologies Inc | 6.10% | 6,444 | $51K |
| 4 | BNGO | BioNano Genomics Inc | 5.37% | 29,298 | $45K |
| 5 | ARCT | Arcturus Therapeutics Holdings Inc | 5.24% | 2,434 | $44K |
| 6 | ROIV | ROIVANT SCIENCES LTD | 4.65% | 4,453 | $39K |
| 7 | NNDM | NANO DIMENSION LTD USD 1.0 ADR | 4.65% | 13,335 | $39K |
| 8 | ALKS | ALKERMES PLC | 3.37% | 1,000 | $28K |
| 9 | CBT | Cabot Corp. | 3.09% | 324 | $26K |
| 10 | LRCX | LAM RESEARCH | 3.06% | 51 | $26K |
| 11 | KLAC | KLA-Tencor Corp. | 2.96% | 63 | $25K |
| 12 | TMO | Thermo Fisher Scientific Inc | 2.94% | 44 | $25K |
| 13 | LITE | LUMENTUM HLDGS INC USD 0.001 | 2.92% | 417 | $24K |
| 14 | ALNY | Alnylam Pharmaceuticals Inc | 2.84% | 108 | $24K |
| 15 | JAZZ | JAZZ PHARMACEUTICALS PLC USD 0.0001 | 2.79% | 159 | $23K |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | N/A | — | ||
| 1W | N/A | — | ||
| 1M | N/A | — | ||
| 3M | N/A | — | ||
| 6M | N/A | — | ||
| YTD | N/A | — | ||
| 1Y | N/A | — | ||
| 3Y | N/A | — | ||
| 5Y | -30.35% | — |
Moving Averages
20-Day MA
N/A
50-Day MA
N/A
200-Day MA
N/A
Price with Moving Averages
Support & Resistance
52-Week High
N/A
Current Price
N/A
52-Week Low
N/A
Current Yield
N/A
Annual Dividend
N/A
Frequency
N/A
Last Ex-Date
N/A
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | TYNE | Healthcare(223 ETFs) | Technology(836 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.65% | 0.60% | 0.88% |
| AUM | $1.3M | $1.25B | $2.08B |
| Dividend Yield | — | 2.75% | 10.67% |
| Avg Volume | N/A | 800.6K | 1.6M |
| Holdings | 31 | 182 | 116 |
| Performance | |||
| 1-Month Return | — | -4.49% | -4.00% |
| 6-Month Return | — | +4.92% | +0.08% |
| YTD Return | — | -1.66% | -2.58% |
| 1-Year Return | — | +15.04% | +20.64% |
Compare with Another ETF
Search for an ETF to compare with TYNE: